ASK REDCHAT ANYTHING ABOUT MINERVA NEUROSCIENCES INC
Minerva Neurosciences Inc (NASDAQ: NERV)
Listen to this Section
$4.76
-0.0200
(
-0.42% )
N/A
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Seltorexant (Orexin2 antagonist)DetailsInsomnia, Mood disorders |
Failed |
Market Data
|
| Open |
$4.76 |
| Previous Close |
$4.78 |
| Volume |
N/A |
| Market Cap |
$218.04M |
| Day Range |
$4.73 - $4.82 |
| 52 Week Range |
$1.57 - $12.46 |
| Shares Outstanding |
46.59M |
| Change % |
-0.42% |
| Net Change |
▼ -0.0200 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-292,850.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-10-05 |
Sale |
-42850.00 |
Ahlholm Frederick W |
| 2023-10-05 |
Sale |
-87050.00 |
Race Geoff |
| 2023-10-05 |
Sale |
-100450.00 |
Luthringer Remy |
| 2023-09-29 |
Sale |
-12500.00 |
Laghrissi-Thode Fouzia |
| 2023-09-29 |
Sale |
-12500.00 |
Kupfer David |
| 2023-09-29 |
Sale |
-12500.00 |
HILLEMAN JERYL L |
| 2023-09-29 |
Sale |
-12500.00 |
VAN HEEK G JAN |
| 2023-09-29 |
Sale |
-12500.00 |
HASLER HANS PETER |